G01N 2333/135
Respiratory syncytial virus
G01N2333/135 (Respiratory syncytial virus) appears on 52 US grants and 82 published applications in this corpus.
Search patents in G01N- Granted patents
- 52
- Published applications
- 82
- Assignees
- 62
- Inventors
- 190
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 2 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 8 |
| 2009 | 3 | 0 |
| 2010 | 5 | 7 |
| 2011 | 1 | 3 |
| 2012 | 1 | 0 |
| 2013 | 2 | 2 |
| 2014 | 0 | 5 |
| 2015 | 4 | 3 |
| 2016 | 4 | 5 |
| 2017 | 1 | 5 |
| 2018 | 8 | 1 |
| 2019 | 2 | 5 |
| 2020 | 0 | 2 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 0 | 3 |
| 2024 | 2 | 10 |
| 2025 | 1 | 3 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunoassay method and immunoassay apparatus24 Mar 2026US 12,584,908 B2Denka Company Limited
- Anti-RS virus-recognizing antibody, and immunoassay method and immunoassay apparatus using the antibody13 Jan 2026US 12,522,650 B2Denka Company Limited
- Nasopharyngeal protein biomarkers of acute respiratory virus infection and methods of using same11 Mar 2025US 12,247,977 B2Duke University
- Specific monoclonal antibody against the N antigen of human respiratory syncytial virus (hRSV) useful for treating infection, detection thereof and diagnosis20 Aug 2024US 12,065,484 B2
- Recombinant RSV G proteins and their use20 Feb 2024US 11,905,313 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- System and Method for Single Protein Detection by Digital Plasmonic Nanobubbles8 Oct 2026US 2026/0309704 A1Board of Regents, The University of Texas System
- Rsv vaccine composition, method and use thereof10 Sep 2026US 2026/0263581 A1Sichuan Clover Biopharmaceuticals, Inc.
- Multiparametric integrated molecular detection of viral antigens and viral nucleic acids23 Jul 2026US 2026/0210962 A1Ohio State Innovation Foundation
- Truncated respiratory syncytial virus f protein and use thereof28 May 2026US 2026/0144858 A1Xiamen Innovax Biotech Co., Ltd.
- Anti-respiratory syncytial virus antibody and related use thereof30 Apr 2026US 2026/0116955 A1Heavybio, Inc
Most cited
By later US patents
- Methods and kits for the amplification of thin film based assays158US 5,955,377 ABiostar, Inc. · 1999
- Methods and apparatus for conducting multiple measurements on a sample125US 7,858,321 B2Meso Scale Technologies, LLC. · 2010
- Assay for directly detecting a RS virus related biological cell in a body fluid sample50US 6,790,611 B2BESST-TEST ApS · 2004
- Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus25US 6,225,091 B1Connaught Laboratories Limited · 2001
- Chimeric immunogens19US 7,671,186 B2Sanofi Pasteur Limited · 2010